Back to Search Start Over

Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.

Authors :
Amini, Mahin
Moradinazar, Mahdi
Rajati, Fatemeh
Soofi, Moslem
Sepanlou, Sadaf G.
Poustchi, Hossein
Eghtesad, Sareh
Moosazadeh, Mahmood
Harooni, Javad
Aghazadeh-Attari, Javad
Fallahi, Majid
Fattahi, Mohammad Reza
Ansari-Moghaddam, Alireza
Moradpour, Farhad
Nejatizadeh, Azim
Shahmoradi, Mehdi
Mansour-Ghanaei, Fariborz
Ostadrahimi, Alireza
Ahmadi, Ali
Khaledifar, Arsalan
Source :
BMC Public Health. 7/21/2022, Vol. 22 Issue 1, p1-11. 11p. 3 Charts, 1 Graph.
Publication Year :
2022

Abstract

<bold>Background: </bold>Elevated blood pressure is associated with cardiovascular disease, stroke and chronic kidney disease. In this study, we examined the socioeconomic inequality and its related factors in prevalence, Awareness, Treatment and Control (ATC) of hypertension (HTN) in Iran.<bold>Method: </bold>The study used data from the recruitment phase of The Prospective Epidemiological Research Studies in IrAN (PERSIAN). A sample of 162,842 adults aged >  = 35 years was analyzed. HTN was defined according to the Joint National Committee)JNC-7(. socioeconomic inequality was measured using concentration index (Cn) and curve.<bold>Results: </bold>The mean age of participants was 49.38(SD =  ± 9.14) years and 44.74% of the them were men. The prevalence of HTN in the total population was 22.3%(95% CI: 20.6%; 24.1%), and 18.8%(95% CI: 16.8%; 20.9%) and 25.2%(95% CI: 24.2%; 27.7%) in men and women, respectively. The percentage of awareness treatment and control among individuals with HTN were 77.5%(95% CI: 73.3%; 81.8%), 82.2%(95% CI: 70.2%; 81.6%) and 75.9%(95% CI: 70.2%; 81.6%), respectively. The Cn for prevalence of HTN was -0.084. Two factors, age (58.46%) and wealth (32.40%), contributed most to the socioeconomic inequality in the prevalence of HTN.<bold>Conclusion: </bold>The prevalence of HTN was higher among low-SES individuals, who also showed higher levels of awareness. However, treatment and control of HTN were more concentrated among those who had higher levels of SES, indicating that people at a higher risk of adverse event related to HTN (the low SES individuals) are not benefiting from the advantage of treatment and control of HTN. Such a gap between diagnosis (prevalence) and control (treatment and control) of HTN needs to be addressed by public health policymakers. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712458
Volume :
22
Issue :
1
Database :
Academic Search Index
Journal :
BMC Public Health
Publication Type :
Academic Journal
Accession number :
158111724
Full Text :
https://doi.org/10.1186/s12889-022-13444-x